Answers are grounded in this paper and cite their sources.
We identified the NF-κB target miR-9-5p as a negative regulator of ABCA1 adding a novel target pathway in the relationship between inflammation and HDL-driven reverse cholesterol transport for prevention or treatment of atherosclerosis in MS.
No takes yet. Share an insight, caveat, or question.
D’Amore et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: